Cundy Thomas P, Marcus Hani J, Hughes-Hallett Archie, Khurana Sanjeev, Darzi Ara
The Hamlyn Centre, Institute of Global Health Innovation, Imperial College London, London, UK.
Department of Paediatric Surgery, Women's and Children's Hospital, Adelaide, South Australia.
Pediatr Surg Int. 2015 Dec;31(12):1119-25. doi: 10.1007/s00383-015-3800-2. Epub 2015 Sep 28.
The role of robot-assisted surgery in children remains controversial. This article aims to distil this debate into an evidence informed decision-making taxonomy; to adopt this technology (1) now, (2) later, or (3) not at all. Robot-assistance is safe, feasible and effective in selected cases as an adjunctive tool to enhance capabilities of minimally invasive surgery, as it is known today. At present, expectations of rigid multi-arm robotic systems to deliver higher quality care are over-estimated and poorly substantiated by evidence. Such systems are associated with high costs. Further comparative effectiveness evidence is needed to define the case-mix for which robot-assistance might be indicated. It seems unlikely that we should expect compelling patient benefits when it is only the mode of minimally invasive surgery that differs. Only large higher-volume institutions that share the robot amongst multiple specialty groups are likely to be able to sustain higher associated costs with today's technology. Nevertheless, there is great potential for next-generation surgical robotics to enable better ways to treat childhood surgical diseases through less invasive techniques that are not possible today. This will demand customized technology for selected patient populations or procedures. Several prototype robots exclusively designed for pediatric use are already under development. Financial affordability must be a high priority to ensure clinical accessibility.
机器人辅助手术在儿童中的作用仍存在争议。本文旨在将这场争论提炼为一种基于证据的决策分类法,以决定是(1)现在采用这项技术,(2)稍后采用,还是(3)根本不采用。如今已知,在某些特定情况下,机器人辅助作为一种辅助工具来增强微创手术能力是安全、可行且有效的。目前,对刚性多臂机器人系统能提供更高质量护理的期望被高估,且证据支持不足。这类系统成本高昂。需要更多的比较有效性证据来确定可能适用机器人辅助的病例组合。如果只是微创手术方式不同,似乎不太可能给患者带来显著益处。只有在多个专业团队间共享机器人的大型高流量机构,才有可能承受当今技术带来的较高相关成本。然而,下一代手术机器人有很大潜力,通过如今尚无法实现的侵入性更小的技术,实现更好地治疗儿童外科疾病的方法。这将需要为特定患者群体或手术定制技术。目前已有几款专门为儿科设计的原型机器人正在研发中。经济可承受性必须成为高度优先考虑的因素,以确保临床可及性。